Related Experiment Videos
Deep molecular remission and encouraging survival without transplantation: V-CAG for arsenic-resistant relapsed APL
Ya-Lan Zhou1, Ting Shi1, Chuan-Ying Geng1
1Department of Haematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
British Journal of Haematology
|August 16, 2026
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Integrated Computational and Functional Screening Identifies G9a Inhibitors for SETD2-mutant Leukemia.
Genomics, proteomics & bioinformatics·2025
A phase IIa study of the anti-PD-L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL-T trial.
British journal of haematology·2026
Pancreatic iron overload as a marker of endocrine complications in transfusion-dependent thalassaemia: A multicentre study.
British journal of haematology·2026
Outcomes of SGLT2 inhibitors after transcatheter mitral valve repair in patients with type 2 diabetes mellitus.
Journal of cardiovascular medicine (Hagerstown, Md.)·2026
A Case Report of Refractory Allergic Bronchopulmonary Aspergillosis: The Art of Selection, Discontinuation and Switching Biologics.
Journal of inflammation research·2026
APRIL-driven BCMA/TACI dual-targeted ligand-drug conjugates for selective and potent therapy of multiple myeloma.
Acta pharmaceutica Sinica. B·2026
Red light-responsive bioorthogonal chemistry enabled on-demand prodrug activation for cancer therapy.
Acta pharmaceutica Sinica. B·2026
Muscle Organoids and Organs-on-Chips: A 15-Year Global Bibliometric Perspective.
Tissue engineering. Part B, Reviews·2026
Allogeneic haematopoietic stem cell transplantation in late-onset metachromatic leukodystrophy.
Brain : a journal of neurology·2026